Michael David Katz M.D., Director at Hanover Bancorp, Inc. /NY (HNVR), bought 700 shares at $18.02 ($13K) on 2024-01-29, disclosed to the SEC on 2024-01-30.
Open-market purchase of $13k HNVR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| HNVR | BUY | 2022-05-11 | $105K | — | Filing → |